|
| related topics |
| {product, liability, claim} |
| {stock, price, operating} |
| {operation, international, foreign} |
| {customer, product, revenue} |
| {product, candidate, development} |
| {system, service, information} |
| {acquisition, growth, future} |
| {product, market, service} |
|
|
The Company May Not Realize Those Anticipated Benefits of Our Acquisition of the Aesthetics Business of Laserscope.
Our Future Success Depends on Our Ability to Develop and Successfully Introduce New Products and New Applications
The Clinical Trial Process Required to Obtain Regulatory Approvals is Costly and Uncertain, and Could Result in Delays in New Product Introductions or Even an Inability to Release a Product.
We Depend on International Sales for a Significant Portion of Our Operating Results
We Are Exposed to Risks Associated With Worldwide Economic Slowdowns and Related Uncertainties.
If We Fail to Accurately Forecast Demand For Our Product and Component Requirements For the Manufacture of Our Product, We Could Incur Additional Costs or Experience Manufacturing Delays and May Experience Lost Sales or Significant Inventory Carrying Costs.
We Face Risks Associated with Our Collaborative and OEM Relationships.
Our Operating Results May Fluctuate from Quarter to Quarter and Year to Year
Our Stock Price Has Been and May Continue to be Volatile and an Investment in Our Common Stock Could Suffer a Decline in Value.
If We Fail to Comply With the FDA s Quality System Regulation and Laser Performance Standards, Our Manufacturing Operations Could Be Halted, and Our Business Would Suffer.
Some of Our Laser Systems Are Complex in Design and May Contain Defects That Are Not Detected Until Deployed By Our Customers, Which Could Increase Our Costs and Reduce Our Revenues.
If Product Liability Claims are Successfully Asserted Against Us, We may Incur Substantial Liabilities That May Adversely Affect Our Business or Results of Operations.
Full 10-K form ▸
|
|
| related documents |
| 768408--6/24/2010--CYANOTECH_CORP |
| 946356--3/9/2007--OAKLEY_INC |
| 911160--6/2/2010--RF_MICRO_DEVICES_INC |
| 1000228--3/10/2006--SCHEIN_HENRY_INC |
| 768408--6/26/2008--CYANOTECH_CORP |
| 1000228--2/26/2008--HENRY_SCHEIN_INC |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 1005010--3/24/2006--ARTHROCARE_CORP |
| 768408--6/25/2009--CYANOTECH_CORP |
| 780127--1/12/2006--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 1125259--1/29/2010--CARNIVAL_CORP |
| 65270--7/1/2010--METHODE_ELECTRONICS_INC |
| 1270597--3/23/2007--MERISANT_CO |
| 18498--4/2/2008--GENESCO_INC |
| 109198--3/31/2009--TJX_COMPANIES_INC_/DE/ |
| 2601--9/13/2006--AEROFLEX_INC |
| 1040130--6/1/2009--PETMED_EXPRESS_INC |
| 1040130--6/1/2010--PETMED_EXPRESS_INC |
| 771252--3/8/2006--DIGITAL_ANGEL_CORP |
| 18498--4/4/2007--GENESCO_INC |
| 780127--1/12/2007--SYNOVIS_LIFE_TECHNOLOGIES__INC |
| 924940--6/14/2006--DIAMONDCLUSTER_INTERNATIONAL_INC |
| 313143--5/27/2008--HAEMONETICS_CORP |
| 1281226--6/15/2006--SENSUS_METERING_SYSTEMS_INC |
| 1281223--6/15/2006--SENSUS_METERING_SYSTEMS_INC |
| 736822--7/24/2008--IMMUCOR_INC |
| 1012019--3/12/2010--RUSH_ENTERPRISES_INC_\TX\ |
| 77597--1/14/2010--SPARTECH_CORP |
| 916459--2/26/2010--GARDNER_DENVER_INC |
| 18498--4/1/2009--GENESCO_INC |
|